Fatigue Management in HIV

Fatigue Management in HIV: A Sleep and Circadian Rhythm Pilot Intervention

This randomized clinical trial (RCT) pilot study as two main objectives:

  • determine the overall feasibility of a behavioral intervention for managing fatigue among older adults with HIV infection.
  • to estimate effect sizes for group differences at 1, 2, and 3 months on five dimensions of fatigue.

The investigators hypothesize that adherence, satisfaction, and attrition will be similar for the active intervention group and the attention control group. The investigators also hypothesize that all five dimensions will improve in the intervention group compared to controls over time, and that Cohen's d (Standard Deviation units) will be greater than 0.5 SD units for all five fatigue dimensions at all three post-intervention time points.

Study Overview

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94143-0606
        • University of California, San Francisco

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have a diagnosis of HIV infection
  • Be at least 50 years of age
  • Have a Fatigue Severity Score13 > 4.0
  • Be retired or on disability
  • Be willing to wear a FitBit One Tracker and keep a 7-day diary at 4 time points (electronic, paper, or other convenient format)
  • Be able to speak, understand, and read English
  • Have a telephone, cell phone, computer access, or other means of communication

Exclusion Criteria:

  • Current temporary, part-time, or full-time employment
  • Planning to travel or be away from home during the 3-month study time frame
  • Being pre- or peri-menopausal because of fluctuations in vasomotor symptoms over time
  • Taking hormones to treat symptoms of menopause
  • Brief Interview for Mental Status score < 13
  • AIDS dementia diagnosis
  • Diagnosed sleep disorder that would not be responsive to behavioral interventions (sleep apnea, restless legs, etc.).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sleep and Rhythm Intervention
This arm receives a 4-week behavioral intervention aimed at improving sleep and circadian rhythms, and thereby reducing fatigue.
Placebo Comparator: Dietary Modifications
This arm receives a 4-week placebo intervention focused on dietary modifications for reducing fatigue.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Morning fatigue severity
Time Frame: 3 months
self-report ratings of morning fatigue severity (Lee Fatigue Scale)
3 months
Evening fatigue severity
Time Frame: 3 months
self-report ratings of evening fatigue severity (Lee Fatigue Scale)
3 months
Lack of energy - frequency
Time Frame: 3 months
self-report rating of the frequency of a lack of energy in past week (single item from Memorial Symptom Assessment Scale)
3 months
Lack of energy - severity
Time Frame: 3 months
self-report rating of the severity of a lack of energy in past week (single item from Memorial Symptom Assessment Scale)
3 months
Lack of energy - distress
Time Frame: 3 months
self-report rating of the distress due to a lack of energy in past week (single item from Memorial Symptom Assessment Scale)
3 months
Attrition
Time Frame: 3 months
Proportion of participants who do not complete the study
3 months
Satisfaction with the intervention
Time Frame: 3 months
Ratings of participant satisfaction with the 6 intervention components
3 months
Adherence to intervention
Time Frame: 3 months
Self-reported adherence to each of the 6 behavioral intervention components
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objectively measured sleep duration
Time Frame: 3 months
Mean night-time sleep duration in minutes during the 7-day assessment period as estimated by FitBit monitor.
3 months
Objectively measured sleep quality
Time Frame: 3 months
Mean number of night-time wakes during the 7-day assessment period as estimated by FitBit monitor.
3 months
Objectively-measured activity
Time Frame: 3 months
Mean number of daily steps during 7-day assessment period
3 months
Sleep medication use
Time Frame: 3 months
Self-reported use of sleep medication during the 7-day assessment period
3 months
Self-reported sleep quality
Time Frame: 3 months
Pittsburgh Sleep Quality Index (PSQI) total score
3 months
Depressed mood
Time Frame: 3 months
Hospital Anxiety and Depression Scale (HADS) - depression subscore
3 months
Anxious mood
Time Frame: 3 months
Hospital Anxiety and Depression Scale (HADS) - anxiety subscore
3 months
Physical function
Time Frame: 3 months
Short Form (SF)-36 physical function score
3 months
Cognitive function
Time Frame: 3 months
SF-36 cognitive function score
3 months
Medication adherence
Time Frame: 3 months
AIDS Clinical Trials Group (ACTG) Adherence score
3 months
Daytime sleepiness
Time Frame: 3 months
Epworth Sleepiness Scale (ESS) - total score
3 months
Fatigue interference with daytime function
Time Frame: 3 months
Fatigue Severity Scale - mean score
3 months
Sleep behavior
Time Frame: 3 months
Sleep Behavior Self-Rating Scale (SBSRS) - total score
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kathryn A Lee, PhD, University of California, San Francisco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

September 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

April 25, 2014

First Submitted That Met QC Criteria

April 28, 2014

First Posted (Estimate)

April 29, 2014

Study Record Updates

Last Update Posted (Estimate)

June 2, 2016

Last Update Submitted That Met QC Criteria

June 1, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HIV-fatigue

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Sleep and Rhythm Intervention

Subscribe